Expression of transforming growth factor-? mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma

Authors:
  • JKJeong A. Kim
    Jeong A. Kim

Abstract
BACKGROUND Transforming growth factor‐α (TGFα) is an important autocrine growth factor of hepatocytes. The authors evaluated the roles of TGFα in chronic viral hepatitis (CVH) and hepatocellular carcinoma (HCC). METHODS The authors measured the amounts of TGFα mRNA in liver tissues from 18 patients with HCC, 31 patients with CVH, and 7 normal controls. “ Hot‐start” reverse transcription‐polymerase chain reaction (RT‐PCR) using oligo‐dT and specific primers detected TGFα mRNA in total cellular RNA extracted from liver tissues. The levels of TGFα mRNA were determined by the end point titers of serial, two‐fold dilutions of cDNA. The amounts of hepatitis B virus RNA (HBV‐RNA) in livers of patients with chronic hepatitis B also were measured by Northern blot hybridization. RESULTS TGFα mRNA levels were extremely higher in patients with HCC compared with patients with CVH and normal controls, and the levels in patients with CVH also were elevated compared with normal controls. The levels of TGFα mRNA were overexpressed in the underlying livers of patients with HCC compared with patients with CVH, although they were lower than those found in HCC tissues. The levels of TGFα mRNA were higher in samples from patients with chronic hepatitis B than in samples from patients with chronic hepatitis C. The levels of TGFα mRNA were not correlated with serum alanine aminotransferase or HBV‐RNA levels in liver tissues in patients with chronic hepatitis B. However, the expression of TGFα mRNA tended to be higher in the livers of patients with raised serum α‐fetoprotein levels. CONCLUSIONS The overexpression of TGFα mRNA in the liver seems to be associated with the regeneration of hepatocytes rather than hepatic necrosis or viral replication. Also, it may be related closely to the development or progression of HCC, especially in the livers of patients with chronic hepatitis B. Cancer 2000;89:977–82. © 2000 American Cancer Society.

This publication has 22 references indexed in Scilit: